Cargando…

The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study

INTRODUCTION: Preterm birth is associated with increased risk of respiratory symptoms in childhood, often treated with asthma medication. We designed a follow-up study to previous research and investigated whether the association of gestational age with purchasing asthma medication diminishes in adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Damgaard, Anne Louise de Barros, Gregersen, Rasmus, Lange, Theis, Buchvald, Frederik, Hansen, Bo Mølholm, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033435/
https://www.ncbi.nlm.nih.gov/pubmed/29975752
http://dx.doi.org/10.1371/journal.pone.0199884
_version_ 1783337703665827840
author Damgaard, Anne Louise de Barros
Gregersen, Rasmus
Lange, Theis
Buchvald, Frederik
Hansen, Bo Mølholm
Greisen, Gorm
author_facet Damgaard, Anne Louise de Barros
Gregersen, Rasmus
Lange, Theis
Buchvald, Frederik
Hansen, Bo Mølholm
Greisen, Gorm
author_sort Damgaard, Anne Louise de Barros
collection PubMed
description INTRODUCTION: Preterm birth is associated with increased risk of respiratory symptoms in childhood, often treated with asthma medication. We designed a follow-up study to previous research and investigated whether the association of gestational age with purchasing asthma medication diminishes in adulthood. METHODS: We conducted a register-based study of a national cohort of all infants born in Denmark in 1980–2009 evaluating longitudinal data on individually prescribed asthma medication (both inhaled ß-2 receptor agonist and different controller treatment over 2-year periods) available from 1995–2011. We analyzed the effect of gestational age considering age, birth year, and perinatal variables using logistic regression with a Generalized Estimating Equations model. All data were unambiguously linked through the Civil Registration System. RESULTS: We included 1,819,743 individuals in our study population. We found an inverse dose-response relationship between gestational age and asthma medication in earlier age-groups with a gradual decrease in odds ratios with increasing age and loss of statistical significance in early adulthood (18–31 years). For our oldest generations, there was a significant effect of gestational age (p-value = 0.04), which became insignificant when adjusting for confounding and mediating factors (p = 0.44). There were significant interactions between gestational age and age (p<0.0001) and gestational age and birth year, but these were most important during childhood (0–11 years) and for our youngest generations (born after 1995). CONCLUSION: The strong association between gestational age and purchase of prescription asthma medication weakens with age into early adulthood, in consistence with the results from our previous study. The risk for purchasing medication to treat asthma-like symptoms was higher in more recent birth years, but the effect of gestational age was small beyond 11 years of age. Gestational age per se did not seem to be significant for the development of asthma-like symptoms: most of its effect could be explained by other perinatal factors.
format Online
Article
Text
id pubmed-6033435
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60334352018-07-19 The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study Damgaard, Anne Louise de Barros Gregersen, Rasmus Lange, Theis Buchvald, Frederik Hansen, Bo Mølholm Greisen, Gorm PLoS One Research Article INTRODUCTION: Preterm birth is associated with increased risk of respiratory symptoms in childhood, often treated with asthma medication. We designed a follow-up study to previous research and investigated whether the association of gestational age with purchasing asthma medication diminishes in adulthood. METHODS: We conducted a register-based study of a national cohort of all infants born in Denmark in 1980–2009 evaluating longitudinal data on individually prescribed asthma medication (both inhaled ß-2 receptor agonist and different controller treatment over 2-year periods) available from 1995–2011. We analyzed the effect of gestational age considering age, birth year, and perinatal variables using logistic regression with a Generalized Estimating Equations model. All data were unambiguously linked through the Civil Registration System. RESULTS: We included 1,819,743 individuals in our study population. We found an inverse dose-response relationship between gestational age and asthma medication in earlier age-groups with a gradual decrease in odds ratios with increasing age and loss of statistical significance in early adulthood (18–31 years). For our oldest generations, there was a significant effect of gestational age (p-value = 0.04), which became insignificant when adjusting for confounding and mediating factors (p = 0.44). There were significant interactions between gestational age and age (p<0.0001) and gestational age and birth year, but these were most important during childhood (0–11 years) and for our youngest generations (born after 1995). CONCLUSION: The strong association between gestational age and purchase of prescription asthma medication weakens with age into early adulthood, in consistence with the results from our previous study. The risk for purchasing medication to treat asthma-like symptoms was higher in more recent birth years, but the effect of gestational age was small beyond 11 years of age. Gestational age per se did not seem to be significant for the development of asthma-like symptoms: most of its effect could be explained by other perinatal factors. Public Library of Science 2018-07-05 /pmc/articles/PMC6033435/ /pubmed/29975752 http://dx.doi.org/10.1371/journal.pone.0199884 Text en © 2018 Damgaard et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Damgaard, Anne Louise de Barros
Gregersen, Rasmus
Lange, Theis
Buchvald, Frederik
Hansen, Bo Mølholm
Greisen, Gorm
The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title_full The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title_fullStr The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title_full_unstemmed The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title_short The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study
title_sort increased purchase of asthma medication for individuals born preterm seems to wane with age: a register-based longitudinal national cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033435/
https://www.ncbi.nlm.nih.gov/pubmed/29975752
http://dx.doi.org/10.1371/journal.pone.0199884
work_keys_str_mv AT damgaardannelouisedebarros theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT gregersenrasmus theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT langetheis theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT buchvaldfrederik theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT hansenbomølholm theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT greisengorm theincreasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT damgaardannelouisedebarros increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT gregersenrasmus increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT langetheis increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT buchvaldfrederik increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT hansenbomølholm increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy
AT greisengorm increasedpurchaseofasthmamedicationforindividualsbornpretermseemstowanewithagearegisterbasedlongitudinalnationalcohortstudy